FierceBiotechOriginal article
{"a":[{"_":"Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate","$":{"href":"/biotech/evaxion-scraps-solid-tumor-vaccine-focus-duke-partnered-brain-cancer-candidate","hreflang":"en"}}]}
Neutral
AI Analysis
Summary
Evaxion discontinued development of a next-generation solid tumor vaccine to focus resources on a brain cancer candidate being developed in partnership with Duke University.
Importance:3/10
Sentiment:
0.00
pipeline_updateprogram_terminationresource_allocationoncologypartnership
Read the original article
Published by FierceBiotech on August 17, 2026 9:20 AM
